Serial IGRA screening for lung cancer patients receiving immune checkpoint inhibitors
Not Applicable
- Conditions
- non-small cell lung cancer patients who receiving immune checkpoint inhibitors
- Registration Number
- JPRN-UMIN000036533
- Lead Sponsor
- ational Hospital Organization Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method positive conversion rate of IGRA at a year after induction of immune checkpoint inhibitor therapy
- Secondary Outcome Measures
Name Time Method incidence of active TB at a year after induction of immune checkpoint inhibitor therapy